With multiple variants of concern now present in most countries the attention is turning to when updated vaccines for them will be ready.
CureVac NV inked a deal with Switzerland’s Novartis AG to manufacture the German biopharmaceutical company’s Covid-19 vaccine candidate, CVnCoV.
Anjum Swaroop, Vice President and Head – Intellectual Property, Dr. Reddy’s Laboratories, addresses the intellectual property issues healthcare companies are facing in the time of Covid-19.
Credit: (Photo: Georgia Institute of Technology) With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory...
When Economies Reopen, These Penny Stocks Could Be In the Spotlight
UK chancellor Rishi Sunak has announced a budget loaded with initiatives designed to kick-start the UK’s economy as The post Budget 2021: Sunak focuses on vaccine...
In this roundtable discussion, four experts from academia and industry met to discuss challenges in refining and scaling up AAV production pipelines to meet the increasing...
Pharmacists at the University of Bonn: Substances block key step in coronavirus replication Credit: © V. Namasivayam/Pharmazeutisches Institut/Uni Bonn A research team of pharmacists at the...
The US was not ready for the coronavirus pandemic in 2020. What can public health leaders and policymakers do to make sure we don't face another...
ISA Pharmaceuticals is planning to take its COVID-19 immunotherapy into the clinic, aiming to harness the power of The post ISA plans trials of T-cell boosting...
"Complete Loss Of Trust": Half Of French Home Health Workers Say They'll Resist Taking Vaccine Astounding new figures out of France suggest what is no doubt a...
New Cleveland Clinic-led research published in mBio Credit: Cleveland Clinic CLEVELAND – Researchers from Cleveland Clinic’s Global Center for Pathogen Research & Human Health have developed...
Merck announced on March 1 the voluntary withdrawal of the U.S. indication for Keytruda (pembrolizumab) for the treatment of patients with metastatic small cell lung cancer...
CryoPort outperformed sales expectations for the fourth quarter amid a rebound in clinical trial activity from the COVID-19 impact. Shares of the temperature-controlled logistics and biostorage...
With COVID-19 forcing a shift towards decentralised trials, two digital health firms – Medable and Seqster – have The post Medable, Seqster pair up on real-world...
How Does The J&J Vaccine Compare To Other COVID Vaccines? 4 Questions Answered Authored by Yves Smith via NakedCapitalism.com, We are running this post for one...
There is still no cure for COVID-19, but doctors have several innovative treatments. Some are keeping patients out of the hospital entirely.
Merck will have to wait to see if a Covid-19 therapeutic gained in November through the $425 million acquisition of OncoImmune can receive Emergency Use Authorization...
Pharma’s historic R&D efforts have given us some light at the end of the COVID tunnel. Now it’s The post Deep Dive: Research and Development appeared...
Mayor Bill de Blasio’s chief medical adviser on Feb. 25 downplayed the results of two studies suggesting that a new coronavirus variant found in New York...
The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to...
Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for The post Merck takes on Lilly/Nektar in IL-2...
Bahrain approved Johnson & Johnson’s one-dose Covid-19 vaccine for emergency use, the first country to do so, the National Health Regulatory Authority (NHRA) said on Feb....
Johnson & Johnson’s one-shot coronavirus vaccine is due to be reviewed by an FDA advisory committee on Friday, The post FDA reviewer backs J&J COVID jab...
The Canadian pharmaceutical market is the 10th largest in the world. What are the biggest pharma stocks on the TSX and TSXV? The post 5 Biggest Canadian...
The U.S. Food and Drug Administration accepted for Priority Review Pfizer Inc.’s Biologics License Application for TicoVac, the company's tick-borne encephalitis vaccine for active immunization to...
Covid-19 vaccine makers told Congress on Feb. 23 that U.S. supplies should surge in the coming weeks due to manufacturing expansions and new vaccine authorizations.
The U.S. Food and Drug Administration issued new guidance for vaccine makers as the regulatory agency is preparing for the possibility of needing to approve Covid-19...
Drugmakers should test any Covid-19 vaccines that have been retooled to combat new variants of the coronavirus in clinical trials designed to track the immune response...
GlaxoSmithKline and Sanofi started a new clinical trial of their protein-based Covid-19 vaccine candidate, reviving their efforts against the pandemic after a setback in December delayed...